Table I.
Patient no. | Gender | Age [years] | Histopathology | Dimension [cm] | Pedicle | Skull base | Observation [months] | Status |
---|---|---|---|---|---|---|---|---|
1 | M | 85 | Adenocarcinoma | 2.5 | 1 | 8 | dd | |
2 | F | 56 | Melanoma | 2.7 | 1 | Bone | 20 | afd |
3 | F | 82 | Melanoma | 2 | 19 | afd | ||
4 | M | 79 | Ca adenoid cysticum | 6 | 18 | afd | ||
5 | M | 28 | Hemangiopericytoma | 2.8 | Dura | 17/1* | afd | |
6 | M | 39 | SCC | 2 | 1 | 15 | afd | |
7 | M | 68 | Poorly differ. ca | 2.7 | 14 | afd | ||
8 | F | 77 | SCC | 5 | 1 | 14 | afd | |
9 | F | 65 | Melanoma | 2.9 | 12 | lost | ||
10 | F | 64 | Fibrosarcoma | 3.1 | 1 | 7 | afd | |
11 | F | 75 | Adenocarcinoma | 4.8 | 1 | 4 | afd | |
Mean | 65 | 3.3 | 13.5 |
Dimension – the greatest dimension of the tumor, SCC – squamous cell carcinoma, afd – alive, free of disease, dd – died of disease, Lost – lost in follow-up, Skull base: skull base involvement
The patient was observed for a total of 17 months after the first procedure, and 1 month after reoperation